HETEROARYL-PYRIMIDINONE COMPOUNDS AS PDE2 INHIBITORS
The present invention is directed to substituted pyrimidinone compounds of formula (I) which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 2 (PDE2). The present invention also rela
-
Page/Page column 55; 56
(2016/11/21)
More Articles about upstream products of 64571-37-5